No Data
No Data
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Veeva Systems (VEEV) and Arrowhead Pharmaceuticals (ARWR)
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $173
Morgan Stanley analyst Craig Hettenbach maintains $Veeva Systems(VEEV.US)$ with a sell rating, and maintains the target price at $173.According to TipRanks data, the analyst has a success rate of 59.2
Barclays Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $220
Barclays analyst Saket Kalia maintains $Veeva Systems(VEEV.US)$ with a buy rating, and maintains the target price at $220.According to TipRanks data, the analyst has a success rate of 60.7% and a
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating
Truist Financial analyst Jailendra Singh maintains $Veeva Systems(VEEV.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 34.9% and a total average return of -14.8%
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $204 to $230
On Jul 16, major Wall Street analysts update their ratings for $Veeva Systems(VEEV.US)$, with price targets ranging from $204 to $230.BofA Securities analyst Bradley Sills maintains with a hold
Veeva Systems (VEEV) Receives a Hold From Truist Financial
No Data